Financial Performance - For the three months ended September 30, 2025, net sales decreased to $2,973.5 million from $3,042.7 million in the same period of 2024, representing a decline of 2.3%[19] - Gross profit for the nine months ended September 30, 2025, was $3,306.3 million, down from $3,495.9 million in 2024, reflecting a decrease of 5.4%[19] - The company reported a net loss of $2,936.9 million for the three months ended September 30, 2025, compared to a net income of $228.8 million in the same period of 2024[20] - The company’s comprehensive loss for the three months ended September 30, 2025, was $3,015.1 million, compared to a comprehensive income of $342.8 million in the same period of 2024[20] - Net income for the nine months ended September 30, 2025, was a loss of $2,389.5 million, compared to a profit of $864.0 million for the same period in 2024[25] - The net loss for the third quarter of 2025 was $2,922.0 million, compared to a net income of $865.7 million for the same period in 2023[28] - The company reported a net loss attributable to MCBC of $2,927.6 million for the three months ended September 30, 2025, compared to a net income of $199.8 million in the same period of 2024[116] - The company reported a net loss of $2,152.3 million for the nine months ended September 30, 2025[214] Goodwill and Impairments - Goodwill impairment of $3,645.7 million was recorded in the third quarter of 2025, significantly impacting the operating income[19] - Goodwill impairment recorded was $3,645.7 million, with no such impairment in the previous year[25] - A partial impairment charge of $198.6 million was recognized for the Staropramen family of brands intangible asset in the EMEA&APAC segment during the third quarter of 2025[111] - The carrying value of goodwill decreased to $1,943.5 million as of September 30, 2025, down from $5,582.3 million as of December 31, 2024, due to a partial impairment loss of $3,645.7 million recorded[63][64] - The Blue Run Spirits asset group experienced a full impairment of $75.3 million due to lower sales driven by a challenging macroeconomic environment[70] Assets and Liabilities - Total assets decreased to $22,873.4 million as of September 30, 2025, from $26,064.3 million at the end of 2024, a reduction of 12.3%[23] - Current liabilities increased to $5,344.8 million as of September 30, 2025, compared to $3,045.2 million at the end of 2024, indicating a rise of 75.5%[23] - The company’s total liabilities stood at $12,204.6 million as of September 30, 2025, down from $12,611.6 million at the end of 2024, a decrease of 3.2%[23] - Cash and cash equivalents were reported at $950.2 million as of September 30, 2025, slightly down from $969.3 million at the end of 2024[23] - Total current assets increased to $2,042.9 million from $1,859.8 million as of December 31, 2024[214] - Total current liabilities rose significantly to $4,969.6 million from $2,673.9 million as of December 31, 2024[214] - Total noncurrent liabilities decreased to $6,265.6 million from $8,950.8 million as of December 31, 2024[214] Cash Flow and Investments - Net cash provided by operating activities decreased to $1,243.7 million from $1,415.8 million year-over-year[25] - Net cash used in investing activities was $(635.1) million, compared to $(530.3) million in the prior year[25] - The balance of cash and cash equivalents at the end of the period was $950.2 million, down from $1,021.7 million at the end of the previous year[25] - The company made a minority investment of $88.1 million in Fevertree Drinks plc, with the investment recorded at a fair value of $127.4 million as of September 30, 2025[61] - Capital expenditures for the three months ended September 30, 2025, were $133.1 million, down from $170.8 million in the same period of 2024, indicating a decrease of approximately 22%[118] - Capital expenditures for the nine months ended September 30, 2025, were $404.5 million, a decrease from $424.2 million in the same period of 2024[215] Shareholder Actions - Dividends paid increased to $285.7 million from $279.4 million year-over-year[25] - The company declared dividends totaling $93.4 million in the third quarter of 2025, reflecting a significant cash outflow[28] - Payments for purchases of treasury stock decreased to $332.8 million from $437.4 million[25] - The share repurchase program in 2024 accounted for a total of $334.9 million, indicating a strategic move to enhance shareholder value despite losses[29] - For the three months ended September 30, 2025, the company repurchased 502,212 shares at an aggregate cost of $25.3 million, compared to 1,160,707 shares for $62.7 million in the same period of 2024[40] Market and Operational Challenges - The Americas restructuring plan will eliminate approximately 400 salaried positions by the end of December 2025, with expected restructuring charges between $35 million and $50 million[126] - The company continues to expand its product portfolio beyond traditional beer, including flavored beverages and spirits, aiming to cater to a wider range of consumer segments[119] - Financial volume decreased by 6.0% to 19.385 million hectoliters for the three months ended September 30, 2025, compared to 20.629 million hectoliters in the prior year[135] - Financial volume for the nine months ended September 30, 2025, decreased by 7.2% compared to the prior year, reflecting lower volume across all regions due to a heightened competitive landscape[180] Tax and Regulatory Matters - The effective tax rate for the three months ended September 30, 2025, was 16%, a decrease from 31% in the prior year, primarily due to a $3,645.7 million partial goodwill impairment[99] - The effective tax rate decreased to 14% for the nine months ended September 30, 2025, compared to 25% in the prior year, primarily due to the impact of the goodwill impairment[160] Debt and Financing - As of September 30, 2025, total long-term debt amounted to $6,255.4 million, an increase from $6,126.2 million as of December 31, 2024, reflecting a growth of approximately 2.1%[79] - The company maintained a maximum leverage ratio of 4.00x, calculated as net debt to EBITDA, and was in compliance with all debt covenants as of September 30, 2025[86] - The company had no outstanding borrowings on its $2.0 billion multi-currency revolving credit facility as of September 30, 2025, and December 31, 2024[84] - The company has long-term credit ratings of BBB/Stable Outlook, Baa1/Stable Outlook, and BBB/Stable Outlook from major rating agencies[207]
Molson Coors(TAP_A) - 2025 Q3 - Quarterly Report